The store will not work correctly when cookies are disabled.
2-(3-Oxothiomorpholin-2-yl)-N-[4-(trifluoromethoxy)phenyl]acetamide
ID: ALA4762833
PubChem CID: 162659474
Max Phase: Preclinical
Molecular Formula: C13H13F3N2O3S
Molecular Weight: 334.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CC1SCCNC1=O)Nc1ccc(OC(F)(F)F)cc1
Standard InChI: InChI=1S/C13H13F3N2O3S/c14-13(15,16)21-9-3-1-8(2-4-9)18-11(19)7-10-12(20)17-5-6-22-10/h1-4,10H,5-7H2,(H,17,20)(H,18,19)
Standard InChI Key: WLSYGWZGTYQRLQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
1.5930 -19.7331 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.0078 -20.4466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4182 -19.7305 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.7199 -19.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7199 -20.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4329 -20.8490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1418 -20.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1418 -19.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4329 -19.1980 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.0049 -20.8541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0031 -19.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2889 -19.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5723 -19.2084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8580 -19.6211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1421 -19.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4325 -19.6213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4344 -20.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1519 -20.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8628 -20.4416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2913 -20.4424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7240 -20.8599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3014 -20.8628 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
5 10 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 2 0
17 21 1 0
21 2 1 0
2 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.32 | Molecular Weight (Monoisotopic): 334.0599 | AlogP: 2.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.61 | CX Basic pKa: ┄ | CX LogP: 2.17 | CX LogD: 2.17 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.89 | Np Likeness Score: -1.32 |
References
1. Di Fruscia P,Edfeldt F,Shamovsky I,Collie GW,Aagaard A,Barlind L,Börjesson U,Hansson EL,Lewis RJ,Nilsson MK,Öster L,Pemberton J,Ripa L,Storer RI,Käck H. (2021) Fragment-Based Discovery of Novel Allosteric MEK1 Binders., 12 (2): [PMID:33603979] [10.1021/acsmedchemlett.0c00563] |